Smallpox

UK Firm Spearheads Manufacture Of Modern Vaccine

Published in Medical Letter on the CDC and FDA, November 18th, 2001

U.S. health authorities have turned to a little-known British company to speed development of its first batch of modern vaccines for smallpox, a fatal virus far more infectious than anthrax.

Acambis PLC seems a somewhat unlikely partner for the U.S. Health Department at such a critical moment. It has lost money each year since its founding in 1993, and it has just 150 employees, two-thirds of them at a subsidiary in Cambridge, Massachusetts.

"They've been lucky that they've been in the right place at the right time," said Richard Parkes, a biotechnology analyst at investment bank ING Barings.

Acambis won a $343 million contract...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2001-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry